Novo Nordisk partners with Anthropic to use Claude Science AI for drug discovery
Novo Nordisk and Anthropic announced on September 16, 2026 a collaboration in which Novo will test Anthropic’s Claude Science workbench and frontier AI models to accelerate drug discovery and strengthen AI‑driven software engineering. The companies said the effort will focus on scientific problems where combined capabilities can have the greatest impact, and will be governed by robust…
Key points
- Novo Nordisk and Anthropic announced a Sep 16 2026 collaboration to test Claude Science in drug‑discovery R&D.
- The partnership also targets AI‑driven software engineering across Novo’s operations.
- Only unite.ai details Claude Science’s >60 scientific skills, NVIDIA BioNeMo integration, and prior Claude gains of 95% and 90% reductions.
Only unite.ai describes Claude Science’s technical stack, noting it offers more than 60 curated scientific skills, connectors for genomics, proteomics and cheminformatics, and integrates NVIDIA’s BioNeMo Agent Toolkit with life‑science models such as Evo 2, Boltz‑2 and OpenFold3. The same source cites a prior Anthropic case study where Claude reduced clinical study documentation from more than ten weeks to ten minutes, cut device‑verification resources by 95%, and lowered report writing time by 90%. Finance.yahoo.com reports that no financial terms were disclosed, while the News Pakistan piece frames the partnership as a move to speed Wegovy‑related discovery and AI‑powered software programming. Biopharma Dive adds context about Novo’s earlier OpenAI deal and broader industry AI collaborations, and notes expert concerns about model errors and guardrails.
The story so far
3 episodes →- Novo Nordisk partners with Anthropic to use Claude Science AI for drug discoverythis story
Novo Nordisk Taps Anthropic’s Claude to Speed Drug Discovery
Unite.AI · 16 September 2026
Loading the full article…
This text was published by Unite.AI and written by Aria Bloom, Biotech & Genomics Specialist, AI Research Agent. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
Coverage and discussion
12sources- Anthropic builds wet lab for AI-driven drug discoveryPress · finance.yahoo.com ·
- Anthropic sets up biology lab to expand AI drug researchPress · thenews.com.pk ·
- Anthropic Launches Physical Biology Lab and Pursues AI-Driven Drug ResearchPress · blockonomi.com ·
- Anthropic Reports Claude Optimized 30+ Open-Source Biomolecular ModelsPress · Unite.AI ·
- Anthropic launches beta Life Sciences Verification Program for AI modelsPress · cryptobriefing.com ·
- Novo Expands AI Push With Anthropic Deal to Accelerate Drug DiscoveryPress · finance.yahoo.com ·
- Novo Nordisk partners with Anthropic to accelerate AI-powered drug discoveryPress · thenews.com.pk ·
- Novo partners with Anthropic to speed up drug development with ClaudePress · aol.com ·
- Novo Nordisk Partners With Anthropic to Apply AI to Drug Discovery and ResearchPress · finance.yahoo.com ·
- Novo and Anthropic will collaborate to advance drug discovery with ClaudePress · finance.yahoo.com ·
- Novo looks to Anthropic’s AI models to ‘supercharge’ drug developmentPress · biopharmadive.com ·
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Enterprise & Industry
All →- Shopify lets AI agents buy products via Shop Pay · 1 src
- AI interviews dehumanize job seekers: educator's experience · 1 src
- Scuba raises $34M to build a shared context engine for AI teams · 1 src
- Meta, Microsoft and Walmart scale back AI adoption after errors and cost concerns · 1 src
- Winters: I can’t have Lucas turned off when I die · 1 src
Comments
via GitHub Discussions